Comment on Damages provisions in USMCA IP Chapter, as regards biologic drugs, and patents on surgery and medical procedures
USMCA
The USMCA Provisions on Test Data for Biologic Products
The United States-Mexico-Canada Agreement (USMCA) provisions on the term of protection of test data for new pharmaceutical products has received considerable attention, and in some cases, some inaccurate reports on the agreement have conflated the term for test data protection… Continue Reading